• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Synta Pharmaceuticals Corp

+ Add to Watchlist

SNTA:US

4.4100 USD 0.0350 0.80%

As of 20:10:00 ET on 07/11/2014.

Snapshot for Synta Pharmaceuticals Corp (SNTA)

Open: 4.4100 Day's Range: 4.3100 - 4.4500 Volume: 835,148
Previous Close: 4.3750 52wk Range: 3.7000 - 7.8500 1-Yr Rtn: -15.52%

Stock Chart for SNTA

No chart data available.
  • SNTA:US 4.4100
  • 1D
  • 1M
  • 1Y
4.3750
Interactive SNTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNTA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.2500
Est. EPS (USD) (12/2014) -1.0980
Est. PEG Ratio -
Market Cap (M USD) 411.34
Shares Outstanding (M) 93.27
30 Day Average Volume 1,822,115
Price/Book (mrq) 10.1059
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SNTA

Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.

Keith R GollustChairman/Interim CEOVojo VukovicSenior VP/Chief Medical Ofcr
Arthur McMahon "Art"Senior VP:People OperationsKeith S EhrlichVP:Finance/CFO
More Company Profile & Key Executives for SNTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil